Middle Ear Adenoma. Long-Term Follow-Up of a Rare Neoplasm

2002 ◽  
Vol 23 (6) ◽  
pp. 1010
Author(s):  
Thomas Lenarz

1983 ◽  
Vol 91 (4) ◽  
pp. 437-440 ◽  
Author(s):  
Steven D. Handler ◽  
William P. Potsic ◽  
Roger R. Marsh

A prospective controlled pilot study was undertaken in which Biolite (carbon-coated) ventilation tubes were placed in 44 ears and a conventional silicone tube in the contralateral ear. Long-term follow-up of these patients has revealed little difference in the incidence of tube occlusion or early extrusion. In addition, there were several disadvantages noted with the Biolite tubes: incomplete coating of the tube (especially within the lumen), shedding of the Biolite coating over time, “tattooing” of the tympanic membrane, poor otoscopic visibility, and the higher cost of these tubes. Since the Biolite tube has no documented advantages and, actually, several disadvantages, we believe its use in the treatment of middle ear disorders should be discontinued until significant benefits are demonstrated and present deficiencies are corrected.



1981 ◽  
Vol 74 (5special) ◽  
pp. 913-920
Author(s):  
Kotaro Ukai ◽  
Yasuro Miyoshi ◽  
Yasuo Sakakura ◽  
Mikikazu Yamagiwa ◽  
Yuichi Majima ◽  
...  




Author(s):  
Konstantinos Mantsopoulos ◽  
Vivian Thimsen ◽  
Miguel Goncalves ◽  
Matti Sievert ◽  
Sarina Katrin Müller ◽  
...  


2002 ◽  
Vol 127 (5) ◽  
pp. 480-482 ◽  
Author(s):  
Mohamed A. El-Bitar ◽  
Sukgi S. Choi

Congenital cholesteatoma of the middle ear is a relatively rare entity that is becoming more frequently encountered in the pediatric age group. A high index of suspicion is needed to recognize this entity at an early stage. More challenging is the bilateral occurrence of the lesion that, although still rare, should always be remembered when examining children with congenital cholesteatoma, not only on the initial visit but also on subsequent follow–up. We report the eleventh case of bilateral congenital middle ear cholesteatoma and stress the importance of long–term follow–up in these cases.



1998 ◽  
Vol 77 (2) ◽  
pp. 134-139 ◽  
Author(s):  
John H. Greinwald ◽  
Eric J. Simko

Osteomas of the middle ear are exceedingly rare benign neoplasms. To date, 16 cases have been reported in the literature, the vast majority of which appear as middle ear masses in young males with a progressive conductive hearing loss. In most patients, the diagnosis is confirmed by computed tomography (CT) or at the time of surgical exploration. Although these lesions have been described as slow-growing, no long-term follow-up has been reported. We present the seventeenth case of a middle ear osteoma in a 33-year-old man who remains asymptomatic and wthout evidence of tumor growth after nine years of follow-up. We suggest that asymptomatic middle ear osteomas can be appropriately managed without removal in a select group of patients.



2001 ◽  
Vol 111 (11) ◽  
pp. 2064-2070 ◽  
Author(s):  
Takehisa Saito ◽  
Yasuhiro Manabe ◽  
Yoshiyuki Shibamori ◽  
Takahiro Yamagishi ◽  
Hideki Igawa ◽  
...  


1993 ◽  
Vol 72 (3) ◽  
pp. 197-200 ◽  
Author(s):  
Christian Deguine

The closed technique is the treatment of choice for middle ear cholesteatoma in the opinion of the author. Several interventions may be required. At the onset, the purpose of the systematic second stage procedure was to verify the absence of any residual cholesteatoma. Experience has shown that the interest of this second intervention lies equally in the opportunity to observe the evolution of the otitis disease process, and the tubal status and in the possibility of restoring transmission under optimal conditions, thanks in particular to the utilization of thick silastic sheeting. This technique necessitates, however, a long-term follow-up. On occasion, a third intervention may be required. Despite the iterative nature of this surgery, it should be considered as a form of a logical progression offering the best chances of a successful anatomic and functional outcome for the patient.



2019 ◽  
Vol 42 ◽  
Author(s):  
John P. A. Ioannidis

AbstractNeurobiology-based interventions for mental diseases and searches for useful biomarkers of treatment response have largely failed. Clinical trials should assess interventions related to environmental and social stressors, with long-term follow-up; social rather than biological endpoints; personalized outcomes; and suitable cluster, adaptive, and n-of-1 designs. Labor, education, financial, and other social/political decisions should be evaluated for their impacts on mental disease.



Sign in / Sign up

Export Citation Format

Share Document